Supplementary Table S4.

Mean Relative Abundances (%) of Genera Identified on Differential Analysis Comparing Bacterial Communities in the Samples of HCs Versus in Patients with MF/SS—One-Way ANOVA: HC Versus MF/SS, Organized by Clinical Stage

Genus	HC	Pateints with MF/SS		P-Value
		IA‒IIA	IIB‒IVB
Acinetobacter	1.123	1.181	1.210	0.551
Alishewanella	0.729	0.843	0.803	0.016
Allorhizobium-Neorhizobium-Pararhizobium-Rhizobium	0.729	0.881	0.818	0.002
Atopobium	0.693	0.692	0.739	0.332
Catenococcus	0.984	1.157	1.036	0.015
Dietzia	0.701	0.736	0.750	0.600
Lachnospiraceae NK4A136 group	0.835	0.707	0.813	0.077
Marinobacter	0.761	0.868	0.842	0.044
Paracoccus	0.699	0.858	0.784	0.049
Roseomonas	0.707	0.714	0.869	0.011
Unclassified Clostridiales	0.693	0.720	0.755	0.220
Unclassified Clostridiales family XIII	0.698	0.739	0.669	0.242
Vibrio	0.912	1.096	1.119	0.003

Abbreviations: HC, healthy control; MF, mycosis fungoides; SS, Sézary syndrome.